Launches Sierra Leone, a program of free health care for mothers and children in the pursuit of high maternal and infant mortality, provide to reduce Ernest Bai Koroma, the country’s president said on Tuesday, the Associated Press reports .
Richard Colonno, the company’s Chief Scientific Officer, will present data on its hepatitis C virus NS5A inhibitor program at the 44th Annual Meeting of the European Association for the Study of the Liver in Copenhagen, Denmark (April 22-26, Colonno presents new data on several series of potent NS5A inhibitor in a poster entitled Identification and Profile of potent and selective inhibitors of the HCV NS5A protein – Poster# 875, Saturday 25 April 2009.. Pharmaceuticals,ceuticals, data on its lead hepatitis C virus NS5A inhibitor program at the EASL conference presentationsPresidio Pharmaceuticals announced that Dr.Accuracy, and Re – Energizing Interest Add Type Continuous of glucose Monitoring – report analyzed technologies and commercial factors.
The convergence of of little Elektronik and advanced biocompatible product designs are be hope to a better future on million of diabetic patients worldwide. Glucose monitors, is designed to are implanted and continuous measurement glucose levels who ability to ability of blood sugar control and patients well-being. By the integration of sensor element, Elektronik and a power source in a single packet, implantable blood glucose monitors be creating new ways for caregivers and Your patients with diabetes.